F

Fluidigm Corp
F:FLB

Watchlist Manager
Fluidigm Corp
F:FLB
Watchlist
Price: 1.07 EUR 0.94% Market Closed
Market Cap: 396.4m EUR

Relative Value

The Relative Value of one FLB stock under the Base Case scenario is 0.83 EUR. Compared to the current market price of 1.07 EUR, Fluidigm Corp is Overvalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FLB Relative Value
Base Case
0.83 EUR
Overvaluation 23%
Relative Value
Price
F
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
38
vs Industry
61
Median 3Y
1.9
Median 5Y
2.4
Industry
3.8
Forward
2.8
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-3.6
Industry
30.6
Forward
-4.6
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-4.8
Industry
18.9
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-4.4
Industry
32.2
vs History
68
vs Industry
76
Median 3Y
1
Median 5Y
1.4
Industry
2.5
vs History
61
vs Industry
81
Median 3Y
1
Median 5Y
2.1
Industry
3.6
Forward
1.3
vs History
63
vs Industry
81
Median 3Y
2.1
Median 5Y
4
Industry
8.2
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-3.3
Industry
16.9
Forward
-3.2
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-2.8
Industry
23
Forward
-1.9
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-2.8
Industry
17.6
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-2.6
Industry
23.1
vs History
61
vs Industry
82
Median 3Y
0.5
Median 5Y
1
Industry
2.3

Multiples Across Competitors

FLB Competitors Multiples
Fluidigm Corp Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Fluidigm Corp
F:FLB
405.6m EUR 2.8 -3.6 -2 -1.7
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 393.6 3 803.5 1 333.5 2 720
US
Thermo Fisher Scientific Inc
NYSE:TMO
155.4B USD 3.6 23.6 16.7 23.1
US
Danaher Corp
NYSE:DHR
143B USD 6 37.7 20.9 30.4
KR
Samsung Biologics Co Ltd
KRX:207940
70.6T KRW 14.4 55.2 32 44.5
CH
Lonza Group AG
SIX:LONN
39.4B CHF 6 62.1 22.7 35.4
US
Agilent Technologies Inc
NYSE:A
33.9B USD 5.1 28.8 19.7 23.2
CN
WuXi AppTec Co Ltd
SSE:603259
200.9B CNY 4.9 18 17.3 17.3
US
IQVIA Holdings Inc
NYSE:IQV
27.6B USD 1.8 20.6 11.5 17.1
US
Mettler-Toledo International Inc
NYSE:MTD
24.6B USD 6.3 28.6 21.6 24
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.9B EUR 6.9 96.6 31 54.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
F
Fluidigm Corp
F:FLB
Average EV/EBITDA: 152.7
Negative Multiple: -2
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 333.5
7%
190.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
16.7
6%
2.8
US
Danaher Corp
NYSE:DHR
20.9
7%
3
KR
Samsung Biologics Co Ltd
KRX:207940
32
17%
1.9
CH
Lonza Group AG
SIX:LONN
22.7
18%
1.3
US
Agilent Technologies Inc
NYSE:A
19.7
10%
2
CN
WuXi AppTec Co Ltd
SSE:603259
17.3
24%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
11.5
9%
1.3
US
Mettler-Toledo International Inc
NYSE:MTD
21.6
4%
5.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
31
20%
1.5